IRIS Accounts Production v25.1.4.42 10736946 director 1.10.23 30.9.24 30.9.24 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh107369462023-09-30107369462024-09-30107369462023-10-012024-09-30107369462022-09-30107369462022-10-012023-09-30107369462023-09-3010736946ns15:EnglandWales2023-10-012024-09-3010736946ns14:PoundSterling2023-10-012024-09-3010736946ns10:Director12023-10-012024-09-3010736946ns10:PrivateLimitedCompanyLtd2023-10-012024-09-3010736946ns10:SmallEntities2023-10-012024-09-3010736946ns10:AuditExemptWithAccountantsReport2023-10-012024-09-3010736946ns10:SmallCompaniesRegimeForDirectorsReport2023-10-012024-09-3010736946ns10:SmallCompaniesRegimeForAccounts2023-10-012024-09-3010736946ns10:FullAccounts2023-10-012024-09-3010736946ns10:RegisteredOffice2023-10-012024-09-3010736946ns5:CurrentFinancialInstruments2024-09-3010736946ns5:CurrentFinancialInstruments2023-09-3010736946ns5:ShareCapital2024-09-3010736946ns5:ShareCapital2023-09-3010736946ns5:RetainedEarningsAccumulatedLosses2024-09-3010736946ns5:RetainedEarningsAccumulatedLosses2023-09-3010736946ns5:PlantMachinery2023-10-012024-09-3010736946ns5:PlantMachinery2023-09-3010736946ns5:PlantMachinery2024-09-3010736946ns5:PlantMachinery2023-09-3010736946ns5:WithinOneYearns5:CurrentFinancialInstruments2024-09-3010736946ns5:WithinOneYearns5:CurrentFinancialInstruments2023-09-3010736946ns5:Non-currentFinancialInstrumentsns5:AfterOneYear2024-09-3010736946ns5:Non-currentFinancialInstrumentsns5:AfterOneYear2023-09-30107369461ns10:Director12023-09-30107369461ns10:Director12022-09-30107369461ns10:Director12023-10-012024-09-30107369461ns10:Director12022-10-012023-09-30107369461ns10:Director12024-09-30107369461ns10:Director12023-09-30
REGISTERED NUMBER: 10736946 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 SEPTEMBER 2024

FOR

CHELSEA COLORECTAL INVESTMENTS LTD

CHELSEA COLORECTAL INVESTMENTS LTD (REGISTERED NUMBER: 10736946)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4

Chartered Certified Accountants' Report 7

CHELSEA COLORECTAL INVESTMENTS LTD

COMPANY INFORMATION
FOR THE YEAR ENDED 30 SEPTEMBER 2024







DIRECTOR: O J Warren





REGISTERED OFFICE: The Stables
23b Lenten Street
Alton
Hampshire
GU34 1HG





REGISTERED NUMBER: 10736946 (England and Wales)





ACCOUNTANTS: LFM
Chartered Certified Accountants
The Stables
23b Lenten Street
Alton
Hampshire
GU34 1HG

CHELSEA COLORECTAL INVESTMENTS LTD (REGISTERED NUMBER: 10736946)

BALANCE SHEET
30 SEPTEMBER 2024

2024 2023
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 3,250 3,975
Investments 5 161,735 141,735
164,985 145,710

CURRENT ASSETS
Debtors 6 798,223 515,174
Investments 7 251,645 218,663
Cash at bank 209,627 137,390
1,259,495 871,227
CREDITORS
Amounts falling due within one year 8 560,151 107,103
NET CURRENT ASSETS 699,344 764,124
TOTAL ASSETS LESS CURRENT
LIABILITIES

864,329

909,834

PROVISIONS FOR LIABILITIES 31,599 18,079
NET ASSETS 832,730 891,755

CAPITAL AND RESERVES
Called up share capital 200 200
Retained earnings 832,530 891,555
SHAREHOLDERS' FUNDS 832,730 891,755

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 September 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 September 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

CHELSEA COLORECTAL INVESTMENTS LTD (REGISTERED NUMBER: 10736946)

BALANCE SHEET - continued
30 SEPTEMBER 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 27 June 2025 and were signed by:





O J Warren - Director


CHELSEA COLORECTAL INVESTMENTS LTD (REGISTERED NUMBER: 10736946)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2024

1. STATUTORY INFORMATION

Chelsea Colorectal Investments Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention as modified by the revaluation of certain assets.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 33% on cost

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2023 - 1 ) .

CHELSEA COLORECTAL INVESTMENTS LTD (REGISTERED NUMBER: 10736946)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 SEPTEMBER 2024

4. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 October 2023
and 30 September 2024 7,201
DEPRECIATION
At 1 October 2023 3,226
Charge for year 725
At 30 September 2024 3,951
NET BOOK VALUE
At 30 September 2024 3,250
At 30 September 2023 3,975

5. FIXED ASSET INVESTMENTS
Interest
in other
participatin
interests
£   
COST OR VALUATION
At 1 October 2023 141,735
Additions 20,000
At 30 September 2024 161,735
NET BOOK VALUE
At 30 September 2024 161,735
At 30 September 2023 141,735

Cost or valuation at 30 September 2024 is represented by:

Interest
in other
participatin
interests
£   
Cost 161,735

6. DEBTORS
2024 2023
£    £   
Amounts falling due within one year:
Trade debtors 52,723 47,817
Other debtors 722,234 421,626
774,957 469,443

CHELSEA COLORECTAL INVESTMENTS LTD (REGISTERED NUMBER: 10736946)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 SEPTEMBER 2024

6. DEBTORS - continued
2024 2023
£    £   
Amounts falling due after more than one year:
Other debtors 23,266 45,731

Aggregate amounts 798,223 515,174

7. CURRENT ASSET INVESTMENTS
2024 2023
£    £   
Listed investments 251,645 218,663

8. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Taxation and social security 75,302 99,301
Other creditors 484,849 7,802
560,151 107,103

9. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 30 September 2024 and 30 September 2023:

2024 2023
£    £   
O J Warren
Balance outstanding at start of year 357,600 (120 )
Amounts advanced 333,298 555,832
Amounts repaid (157,918 ) (198,112 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 532,980 357,600

Interest was charged on the overdrawn balance at the rate of 2.25%pa.

CHARTERED CERTIFIED ACCOUNTANTS' REPORT TO THE DIRECTOR
ON THE UNAUDITED FINANCIAL STATEMENTS OF
CHELSEA COLORECTAL INVESTMENTS LTD

The following reproduces the text of the report prepared for the director in respect of the company's annual unaudited financial statements. In accordance with the Companies Act 2006, the company is only required to file a Balance Sheet. Readers are cautioned that the Income Statement and certain other primary statements and the Report of the Director are not required to be filed with the Registrar of Companies.

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Chelsea Colorectal Investments Ltd for the year ended 30 September 2024 which comprise the Income Statement, Balance Sheet and the related notes from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Association of Chartered Certified Accountants, we are subject to its ethical and other professional requirements which are detailed at http://www.accaglobal.com/rulebook.

This report is made solely to the director of Chelsea Colorectal Investments Ltd in accordance with our terms of engagement. Our work has been undertaken solely to prepare for your approval the financial statements of Chelsea Colorectal Investments Ltd and state those matters that we have agreed to state to the director of Chelsea Colorectal Investments Ltd in this report in accordance with the requirements of the Association of Chartered Certified Accountants as detailed at
https://www.accaglobal.com/content/dam/ACCA_Global/Technical/fact/tf-163-jan-24.pdf.

To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and its director for our work or for this report.

It is your duty to ensure that Chelsea Colorectal Investments Ltd has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of Chelsea Colorectal Investments Ltd. You consider that Chelsea Colorectal Investments Ltd is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the financial statements of Chelsea Colorectal Investments Ltd. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.






LFM
Chartered Certified Accountants
The Stables
23b Lenten Street
Alton
Hampshire
GU34 1HG


27 June 2025